These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34830641)

  • 21. Appearance of hepatobiliary diseases in a population-based cohort with inflammatory bowel diseases (Inflammatory Bowel Disease Cohort of the Uppsala Region).
    Rönnblom A; Holmström T; Tanghöj H; Rorsman F; Sjöberg D
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1288-92. PubMed ID: 25777994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
    de Vries AB; Janse M; Blokzijl H; Weersma RK
    World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal Liver Biochemistry Is Common in Pediatric Inflammatory Bowel Disease: Prevalence and Associations.
    Valentino PL; Feldman BM; Walters TD; Griffiths AM; Ling SC; Pullenayegum EM; Kamath BM
    Inflamm Bowel Dis; 2015 Dec; 21(12):2848-56. PubMed ID: 26273817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease.
    Heikius B; Niemelä S; Lehtola J; Karttunen T; Lähde S
    Scand J Gastroenterol; 1997 Feb; 32(2):153-61. PubMed ID: 9051876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease.
    Lunder AK; Hov JR; Borthne A; Gleditsch J; Johannesen G; Tveit K; Viktil E; Henriksen M; Hovde Ø; Huppertz-Hauss G; Høie O; Høivik ML; Monstad I; Solberg IC; Jahnsen J; Karlsen TH; Moum B; Vatn M; Negård A
    Gastroenterology; 2016 Oct; 151(4):660-669.e4. PubMed ID: 27342213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease.
    Weng MT; Shih IL; Tung CC; Leong YL; Shieh MJ; Wang CY; Wong JM; Ni YH; Wei SC
    Intest Res; 2022 Apr; 20(2):224-230. PubMed ID: 35124955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colitis-associated sclerosing cholangitis in children: a single centre experience.
    Noble-Jamieson G; Heuschkel RB; Torrente F; Hadzic N; Zilbauer M
    J Crohns Colitis; 2013 Nov; 7(10):e414-8. PubMed ID: 23485432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M
    Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.
    Saich R; Chapman R
    World J Gastroenterol; 2008 Jan; 14(3):331-7. PubMed ID: 18200656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P049 Investigation of Liver Diseases by Ultrasound in Patients With Inflammatory Bowel Disease.
    Shintaku D; Lopes M; de Oliveira AC; Beraldo R; Godoi G; Castelhano N; Pereira J; Vulcano D; de Oliveira EC; Herrerias G; Saad-Hossne R; Baima J; Barbosa W; Silva G; Sassaki L
    Am J Gastroenterol; 2021 Dec; 116(Suppl 1):S12-S13. PubMed ID: 37461967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary sclerosing cholangitis in patients with inflammatory bowel disease in Turkey.
    Parlak E; Kosar Y; Ulker A; Dagli U; Alkim C; Sahin B
    J Clin Gastroenterol; 2001 Oct; 33(4):299-301. PubMed ID: 11588543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation.
    Aranake-Chrisinger J; Dassopoulos T; Yan Y; Nalbantoglu I
    World J Gastroenterol; 2020 Jul; 26(28):4126-4139. PubMed ID: 32821074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sclerosing Cholangitis in Pediatric Inflammatory Bowel Disease: Early Diagnosis and Management Affect Clinical Outcome.
    Hensel KO; Kyrana E; Hadzic N; Mann J; Mieli-Vergani G; Gasparetto M; Heuschkel R; Noble-Jamieson G; Samyn M
    J Pediatr; 2021 Nov; 238():50-56.e3. PubMed ID: 34303727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.
    Fousekis FS; Theopistos VI; Katsanos KH; Tsianos EV; Christodoulou DK
    Gastroenterology Res; 2018 Apr; 11(2):83-94. PubMed ID: 29707074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.
    Boonstra K; van Erpecum KJ; van Nieuwkerk KM; Drenth JP; Poen AC; Witteman BJ; Tuynman HA; Beuers U; Ponsioen CY
    Inflamm Bowel Dis; 2012 Dec; 18(12):2270-6. PubMed ID: 22407885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study.
    Valentino PL; Wiggins S; Harney S; Raza R; Lee CK; Jonas MM
    J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):603-609. PubMed ID: 27504812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
    Ricciuto A; Fish J; Carman N; Walters TD; Church PC; Hansen BE; Crowley E; Siddiqui I; Nguyen GC; Kamath BM; Griffiths AM
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1098-1105.e1. PubMed ID: 29378308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatopancreatobiliary manifestations of inflammatory bowel disease.
    Nakamura K; Ito T; Kotoh K; Ihara E; Ogino H; Iwasa T; Tanaka Y; Iboshi Y; Takayanagi R
    Clin J Gastroenterol; 2012 Feb; 5(1):1-8. PubMed ID: 26181867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver manifestations and complications in inflammatory bowel disease: A review.
    Gaspar R; Branco CC; Macedo G
    World J Hepatol; 2021 Dec; 13(12):1956-1967. PubMed ID: 35070000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver biopsy in inflammatory bowel disease patients with sustained abnormal liver function tests: a retrospective single-center study.
    Dias E; Andrade P; Lopes S; Gonçalves R; Cardoso P; Gaspar R; Cardoso H; Lopes J; Carneiro F; Macedo G
    Ann Gastroenterol; 2023; 36(1):54-60. PubMed ID: 36593810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.